Compound Evidence File
#EC-2026-0299
Dianabol Raw
Filed under Raw Materials. The bureau holds 105 laboratory returns for this compound from 33 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
33 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 10 Jan 2026 | 16 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 10.0 | 10.0 | 17 Mar 2026 | 2 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 6 Nov 2025 | 14 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 9.9 | 10.0 | 9 Jan 2026 | 7 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Jan 2026 | 17 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 17 Dec 2025 | 18 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 10.0 | 10.0 | 2 Feb 2026 | 17 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 22 Jun 2026 | 11 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 10.0 | 10.0 | 10.0 | 22 Mar 2026 | 10 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 10.0 | 10.0 | 10.0 | 27 Mar 2026 | 8 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 4 Feb 2026 | 3 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 9.9 | 9.9 | 10.0 | 22 Mar 2026 | 7 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 22 Nov 2025 | 14 Feb 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 9.4 | 9.4 | 9.4 | 13 Jun 2025 | 13 Jun 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.8 | 7.5 | 9.9 | 23 May 2026 | 23 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 8.8 | 8.3 | 9.3 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.7 | 7.9 | 9.2 | 21 May 2026 | 21 May 2026 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 8.5 | 8.5 | 8.5 | 25 Apr 2025 | 25 Apr 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.3 | 6.2 | 10.0 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 7.8 | 6.7 | 9.6 | 23 May 2026 | 23 May 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 7.3 | 7.3 | 7.3 | 11 Jun 2025 | 11 Jun 2025 |
| Planet PeptideCASE #VI-2026-0092 | X | 5 | 7.2 | 5.8 | 8.0 | 17 Dec 2024 | 17 May 2026 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 3 | 7.1 | 6.4 | 7.9 | 9 Jun 2025 | 24 May 2026 |
| NexaphCASE #VI-2026-0944 | X | 5 | 7.0 | 5.8 | 8.8 | 13 Jun 2025 | 20 May 2026 |
| LSPLCASE #VI-2026-0523 | X | 3 | 6.7 | 5.9 | 7.7 | 16 Mar 2025 | 21 May 2026 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 6.5 | 6.5 | 6.5 | 27 Feb 2025 | 27 Feb 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 5.8 | 5.8 | 5.8 | 20 Jun 2025 | 20 Jun 2025 |
| Peptide GurusCASE #VI-2026-0854 | X | 1 | 5.3 | 5.3 | 5.3 | 8 Jul 2025 | 8 Jul 2025 |
| ScienceCASE #VI-2026-0636 | X | 1 | 4.2 | 4.2 | 4.2 | 24 Apr 2025 | 24 Apr 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 1 | 3.4 | 3.4 | 3.4 | 21 May 2025 | 21 May 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Jun 2025 | 13 Jun 2025 |
Open any subject to view the batch-level evidence for Dianabol Raw alone.